This website is no longer being maintained by Stretto but has been archived and certain content remains available for reference.

On April 7, 2023 (the "Petition Date"), Pear Therapeutics, Inc., and one (1) affiliated debtor (collectively, the "Debtors"), filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code. The Debtors' bankruptcy cases are jointly administrated under Case No. 23-10429 before Honorable Thomas M Horan in the United States Bankruptcy Court for the District of Delaware (the "Bankruptcy Court").

An Order and Final Decree Pursuant to Sections 105(a) and 350(a) of the Bankruptcy Code and Bankruptcy Rule 3022 (I) Issuing a Final Decree Closing This Chapter 11 Case, (II) Terminating the Claims Agent, (III) Approving Treatment of Unclaimed Distributions, (IV) Authorizing the Disposition of Residual Funds, (V) Authorizing the Destruction of Certain Documents, and (VI) Granting Related Relief has been entered.